Long-term safety and efficacy of bilastine following up to 12 weeks or 52 weeks of treatment in Japanese patients with allergic rhinitis: Results of an open-label trial-Reference-Cited by-同舟云学术

Long-term safety and efficacy of bilastine following up to 12 weeks or 52 weeks of treatment in Japanese patients with allergic rhinitis: Results of an open-label trial

Published:2017-06 Issue:3 Volume:44 Page:294-301
ISSN:0385-8146
Container-title:Auris Nasus Larynx
language:en
Short-container-title:Auris Nasus Larynx

Author:

Okubo Kimihiro,Gotoh Minoru,Togawa Michinori^ORCID,Saito Akihiro,Ohashi Yoshihiro

Funder

Taiho Pharmaceutical Co., Tokyo, Japan

Publisher

Elsevier BV

Subject

General Medicine,Otorhinolaryngology,Surgery

Reference11 articles.

1. WAO white book on allergy 2013 update;Pawankar,2013

2. Japanese guideline for allergic rhinitis 2014;Okubo;Allergol Int,2014

3. Clinical practice guideline: allergic rhinitis;Seidman;Otolaryngol Head Neck Surg,2015

4. Examination, diagnosis and classification for Japanese allergic rhinitis: Japanese guideline;Fujieda;Auris Nasus Larynx,2012

5. Selecting the oral antihistamine for patients with allergic rhinitis;Lehman;Drugs,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial;European Journal of Pharmaceutical Sciences;2024-12

2. Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study;Drugs in Context;2024-05-01

3. Traditional Chinese Herbal Medicine for Allergic Diseases: A Review;The American Journal of Chinese Medicine;2023-01

4. SAFETY AND CLINICAL EFFECTIVENESS OF BILASTINE IN THE TREATMENT OF ALLERGIC RHINITIS IN CHILDREN;World of Medicine and Biology;2022

5. How bilastine is used to treat allergic rhinitis and urticaria in children;Immunotherapy;2022-01